CPRX Q4 2018 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$500,000

Gross Profit

-$8M-1583.4% margin

Operating Income

-$15M-2968.7% margin

Net Income

-$14M-2899.9% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$60M

Total Liabilities

$10M

Stockholders' Equity

$51M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$500,000	$0	—
Gross Profit	-$8M	-$3M	-132.5%
Operating Income	-$15M	-$6M	-169.3%
Net Income	-$14M	-$5M	-169.1%